Yash Shah
Neurology with Special Qualifications in Child Neurology · Baton Rouge, LANPI 1487107074
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.2%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Livanova USA, Inc. at 39.0% of the total. 2025 is the largest year on record at $4,338, more than ten times the $267 reported in 2022.
Across 125 payments — averaging $68.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$3K
- Acadia Pharmaceuticals Inc$1K
- DIXI Medical USA Corp$852
- UCB, Inc.$602
- Jazz Pharmaceuticals Inc.$478
- Biogen$342
- plus $2K from 21 others
Across 1 payment — averaging $6500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- UCB SA$7K
What the payments were for
- Consulting fees$1,35016%
- Speaking & faculty fees$2,87033%
- Food & beverage$4,22949%
- Education$1542%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 9 | $3,357 |
| Acadia Pharmaceuticals Inc | 6 | $1,448 |
| DIXI Medical USA Corp | 1 | $852 |
| UCB, Inc. | 19 | $602 |
| Jazz Pharmaceuticals Inc. | 25 | $478 |
| Biogen | 14 | $342 |
| Neurelis, Inc. | 8 | $293 |
| Genentech USA, Inc. | 12 | $242 |
| Zevra Therapeutics Inc | 1 | $143 |
| Novartis | 1 | $94 |
| Astellas Pharma US Inc | 1 | $94 |
| Supernus Pharmaceuticals, Inc. | 4 | $88 |
| Beone Medicines USA, Inc. | 4 | $80 |
| Biocodex, Inc. | 1 | $73 |
| Beigene USA, Inc. | 3 | $60 |
| Corium, LLC | 3 | $52 |
| Upsher-smith Laboratories LLC | 2 | $45 |
| Ironshore Pharmaceuticals Inc. | 2 | $40 |
| Genentech, Inc. | 1 | $36 |
| Sarepta Therapeutics, Inc. | 1 | $34 |
| Azurity Pharmaceuticals, Inc. | 1 | $26 |
| Johnson & Johnson | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Immedica Pharma US, Inc. | 1 | $24 |
| AstraZeneca | 1 | $23 |
| Eisai Inc. | 1 | $18 |
| Aucta Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$2,870
- DAYBUE$1,350
- VNS Therapy$268
- Olpruva$143
- VALTOCO$112
How this compares
$8,603 in reported general payments places this provider in the 65th percentile of 30 neurology with special qualifications in child neurology providers in Louisiana.
See all neurology with special qualifications in child neurology providers in Louisiana →
Other neurology with special qualifications in child neurology in Baton Rouge
- Shannon McGuireBaton Rouge$10K
- Jocelyn LorenzoBaton Rouge$3K
- Lalania SchexnayderBaton Rouge$2K
- Chad ManuelBaton Rouge$2K
- Thomas EnlowBaton Rouge$2K
- Aristotel Pena-MichesMonroe$207K
- Ann Henderson TiltonNew Orleans$119K
- Cresha DavisWest Monroe$73K
- Joaquin WongNew Orleans$28K
- Allison ConraveyNew Orleans$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.